Capital Market Strategies LLC Sells 629 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

Capital Market Strategies LLC reduced its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 7.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 8,372 shares of the company’s stock after selling 629 shares during the period. Capital Market Strategies LLC’s holdings in ARK Genomic Revolution ETF were worth $214,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. EverSource Wealth Advisors LLC purchased a new stake in shares of ARK Genomic Revolution ETF during the 1st quarter valued at $49,000. Park Avenue Securities LLC raised its position in shares of ARK Genomic Revolution ETF by 14.0% during the 1st quarter. Park Avenue Securities LLC now owns 11,667 shares of the company’s stock valued at $336,000 after buying an additional 1,435 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of ARK Genomic Revolution ETF by 271.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock valued at $21,090,000 after buying an additional 469,740 shares in the last quarter. Cetera Investment Advisers raised its position in shares of ARK Genomic Revolution ETF by 290.7% during the 1st quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock valued at $4,052,000 after buying an additional 104,831 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its position in shares of ARK Genomic Revolution ETF by 14.2% during the 1st quarter. Janney Montgomery Scott LLC now owns 8,425 shares of the company’s stock valued at $242,000 after buying an additional 1,045 shares in the last quarter.

ARK Genomic Revolution ETF Stock Performance

ARKG stock opened at $24.41 on Friday. The firm’s 50 day simple moving average is $25.66 and its two-hundred day simple moving average is $25.55.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.